Predictors of Treatment (Tx) Response and Progression in Braf V600E Metastatic Melanoma (Mm) Patients (Pts) with Brain Metastases (Bm) Receiving Vemurafenib (Vem) in a Real-World Setting
Year: 2014
Type: article
Study design: Observational Study
Source: Annals of Oncology
Institutions: Moffitt Cancer Center, Analysis Group (United States), Genentech
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W1762532995
